Invesco’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.02B | Sell |
3,905,109
-6,387
| -0.2% | -$4.89M | 0.29% | 49 |
|
|
2025
Q4 | $3.02B | Buy |
3,911,496
+2,427,023
| +163% | +$1.65B | 0.28% | 52 |
|
|
2025
Q3 | $835M | Buy |
1,484,473
+408,649
| +38% | +$231M | 0.13% | 161 |
|
|
2025
Q2 | $565M | Buy |
1,075,824
+225,078
| +26% | +$126M | 0.1% | 238 |
|
|
2025
Q1 | $540M | Sell |
850,746
-13,503
| -2% | -$9.29M | 0.1% | 233 |
|
|
2024
Q4 | $616M | Sell |
864,249
-296,924
| -26% | -$249M | 0.11% | 201 |
|
|
2024
Q3 | $1.22B | Buy |
1,161,173
+244,753
| +27% | +$272M | 0.24% | 68 |
|
|
2024
Q2 | $963M | Sell |
916,420
-69,648
| -7% | -$67.5M | 0.2% | 88 |
|
|
2024
Q1 | $949M | Buy |
986,068
+221,061
| +29% | +$210M | 0.2% | 87 |
|
|
2023
Q4 | $672M | Buy |
765,007
+21,659
| +3% | +$17.8M | 0.16% | 133 |
|
|
2023
Q3 | $612M | Sell |
743,348
-165,714
| -18% | -$130M | 0.16% | 134 |
|
|
2023
Q2 | $653M | Buy |
909,062
+24,307
| +3% | +$18.7M | 0.17% | 121 |
|
|
2023
Q1 | $727M | Buy |
884,755
+191,892
| +28% | +$145M | 0.2% | 98 |
|
|
2022
Q4 | $500M | Buy |
692,863
+51,541
| +8% | +$38M | 0.15% | 160 |
|
|
2022
Q3 | $442M | Buy |
641,322
+13,135
| +2% | +$8.27M | 0.14% | 170 |
|
|
2022
Q2 | $371M | Buy |
628,187
+25,256
| +4% | +$16.4M | 0.11% | 223 |
|
|
2022
Q1 | $421M | Buy |
602,931
+14,720
| +3% | +$9.31M | 0.11% | 239 |
|
|
2021
Q4 | $371M | Buy |
588,211
+103,773
| +21% | +$63.8M | 0.09% | 287 |
|
|
2021
Q3 | $293M | Buy |
484,438
+25,958
| +6% | +$16.1M | 0.07% | 345 |
|
|
2021
Q2 | $256M | Sell |
458,480
-10,864
| -2% | -$5.5M | 0.06% | 400 |
|
|
2021
Q1 | $222M | Buy |
469,344
+70,883
| +18% | +$34.5M | 0.06% | 416 |
|
|
2020
Q4 | $193M | Buy |
398,461
+108,214
| +37% | +$58.4M | 0.06% | 443 |
|
|
2020
Q3 | $162M | Buy |
290,247
+31,119
| +12% | +$18.9M | 0.05% | 432 |
|
|
2020
Q2 | $162M | Sell |
259,128
-43,407
| -14% | -$24.6M | 0.06% | 405 |
|
|
2020
Q1 | $148M | Sell |
302,535
-6,820
| -2% | -$2.81M | 0.06% | 371 |
|
|
2019
Q4 | $116M | Sell |
309,355
-1,002,899
| -76% | -$337M | 0.04% | 594 |
|
|
2019
Q3 | $364M | Sell |
1,312,254
-32,019
| -2% | -$9.47M | 0.1% | 235 |
|
|
2019
Q2 | $421M | Buy |
1,344,273
+46,055
| +4% | +$15.3M | 0.11% | 216 |
|
|
2019
Q1 | $533M | Buy |
1,298,218
+66,786
| +5% | +$27.5M | 0.18% | 123 |
|
|
2018
Q4 | $460M | Buy |
1,231,432
+19,546
| +2% | +$7.15M | 0.18% | 128 |
|
|
2018
Q3 | $490M | Buy |
1,211,886
+67,071
| +6% | +$25.5M | 0.15% | 148 |
|
|
2018
Q2 | $395M | Buy |
1,144,815
+108,565
| +10% | +$34M | 0.13% | 173 |
|
|
2018
Q1 | $357M | Buy |
1,036,250
+73,355
| +8% | +$25.5M | 0.13% | 175 |
|
|
2017
Q4 | $362M | Buy |
962,895
+65,519
| +7% | +$26.5M | 0.13% | 184 |
|
|
2017
Q3 | $401M | Sell |
897,376
-33,253
| -4% | -$15.8M | 0.15% | 165 |
|
|
2017
Q2 | $457M | Buy |
930,629
+244
| +0% | +$107K | 0.14% | 158 |
|
|
2017
Q1 | $361M | Buy |
930,385
+42,057
| +5% | +$15.6M | 0.12% | 190 |
|
|
2016
Q4 | $326M | Buy |
888,328
+41,562
| +5% | +$15.8M | 0.11% | 209 |
|
|
2016
Q3 | $340M | Buy |
846,766
+22,483
| +3% | +$9.02M | 0.12% | 200 |
|
|
2016
Q2 | $288M | Sell |
824,283
-179,634
| -18% | -$69.2M | 0.11% | 220 |
|
|
2016
Q1 | $362M | Sell |
1,003,917
-282,066
| -22% | -$116M | 0.15% | 159 |
|
|
2015
Q4 | $698M | Buy |
1,285,983
+234,111
| +22% | +$127M | 0.28% | 67 |
|
|
2015
Q3 | $489M | Buy |
1,051,872
+565
| +0.1% | +$303K | 0.21% | 100 |
|
|
2015
Q2 | $536M | Sell |
1,051,307
-19,322
| -2% | -$9.43M | 0.21% | 102 |
|
|
2015
Q1 | $483M | Sell |
1,070,629
-212,853
| -17% | -$90.2M | 0.19% | 115 |
|
|
2014
Q4 | $527M | Buy |
1,283,482
+134,855
| +12% | +$53M | 0.2% | 112 |
|
|
2014
Q3 | $414M | Buy |
1,148,627
+8,748
| +0.8% | +$2.93M | 0.17% | 135 |
|
|
2014
Q2 | $322M | Sell |
1,139,879
-184,552
| -14% | -$54.7M | 0.13% | 192 |
|
|
2014
Q1 | $398M | Buy |
1,324,431
+81,757
| +7% | +$25.2M | 0.16% | 139 |
|
|
2013
Q4 | $342M | Buy |
1,242,674
+18,862
| +2% | +$5.43M | 0.14% | 164 |
|
|
2013
Q3 | $383M | Buy |
1,223,812
+166,914
| +16% | +$43.9M | 0.17% | 124 |
|
|
2013
Q2 | $238M | Buy |
+1,056,898
| New | +$246M | 0.11% | 207 |
|
Other funds holding REGN
VCM
N
Invesco's REGN Position: Q1 2026 in Review
Invesco reduced its Regeneron Pharmaceuticals (REGN) stake by 0.16% in Q1 2026, selling an estimated $4.89M and leaving 3,905,109 shares worth $3.02B. The position accounts for 0.29% of the portfolio, ranked #49.
Invesco first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.02B in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Invesco held 3,905,109 shares of Regeneron Pharmaceuticals worth $3.02B as of Q1 2026.
- Invesco sold 6,387 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $4.89M.
- Regeneron Pharmaceuticals made up 0.29% of Invesco's portfolio in Q1 2026, its #49 holding.
- Invesco first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Invesco's Regeneron Pharmaceuticals position peaked at $3.02B in Q4 2025.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.